Looks similar
Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%(arstechnica.com)
136 points by _Microft | 25 comments
Ars Technica article reporting Phase 3 results showing Moderna and Merck's personalized mRNA melanoma vaccine with Keytruda cut recurrence or death risk by 42%.
Related stories
Moderna reports first positive Phase 3 for mRNA neoantigen therapy in melanoma(twitter.com)
498 points by heydenberk | 231 comments
X post by Moderna co-founder Noubar Afeyan announcing positive Phase 3 results for intismeran autogene, an individualized mRNA neoantigen therapy for melanoma with Keytruda.
New HIV vaccine shows unprecedented success in preclinical study(lji.org)
615 points by codebyaditya | 262 comments
La Jolla Institute for Immunology news release on a new HIV vaccine approach that produced high levels of HIV-neutralizing antibodies in non-human primates.
We’re secretly winning the war on cancer(vox.com)
365 points by lr0 | 161 comments
Vox Future Perfect article by Bryan Walsh arguing that falling cancer death rates reflect quiet advances like reduced smoking and immunotherapy.
Scientist treated her own cancer with viruses she grew in the lab(nature.com)
570 points by dataminer | 198 comments
Nature news article about virologist Beata Halassy, who treated her own breast cancer with lab-grown oncolytic viruses, and researchers' warnings against copying her.
Scientists Untangle the Biology of an 'Undruggable' Cancer Gene(nytimes.com)
4 points by gumby | 2 comments
New York Times article on scientists working out the biology of a cancer gene long considered undruggable; the capture shows only a captcha page.
Cheap blood test detects pancreatic cancer before it spreads(nature.com)
331 points by rbanffy | 196 comments
Nature news article from February 2025 about an inexpensive blood test that can detect pancreatic cancer before it spreads to other parts of the body.












